The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-23 and is reviewed periodically as new material appears.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
FS−SF → S=SF2 Decomposing to sulfur tetrafluoride and sulfur when heated to 180 °C: 2 S2F2 → SF4 + 3 S Hydrolysis: 2 S2F2 + 2 H2O → SO2 + 3 S + 4 HF Reacting with sulfuric acid at 80 °C: S2F2 + 3 H2SO4 → 5 SO2 + 2 HF + 2 H2O Reacting with sodium hydroxide: 2 S2F2 + 6 NaOH → Na2SO3 + 3 S + 4 NaF + 3 H2O Reacting with oxygen at high pressure, using nitrogen dioxide as a catalyst: 2 S2F2 + 5 O2 → SOF4 + 3 SO3
=== Desired target effect === Identical drugs can produce different results depending on the route of administration. For example, some drugs are not significantly absorbed into the bloodstream from the gastrointestinal tract and their action after enteral administration is therefore different from that after parenteral administration. This can be illustrated by the action of naloxone (Narcan), an antagonist of opiates such as morphine. Naloxone counteracts opiate action in the central nervous system when given intravenously and is therefore used in the treatment of opiate overdose. The same drug, when swallowed, acts exclusively on the bowels; it is here used to treat constipation under opiate pain therapy and does not affect the pain-reducing effect of the opiate.
==== Brain and spinal cord injury ==== Stroke and traumatic brain injury lead to cell death, characterized by a loss of neurons and oligodendrocytes within the brain. Clinical and animal studies have been conducted into the experimental use of stem cells in cases of spinal cord injury.
Sources: en.wikipedia.org
=== Nativity === A native antigen is an antigen that is not yet processed by an APC to smaller parts. T cells cannot bind native antigens, but require that they be processed by APCs, whereas B cells can be activated by native ones.
Some cultures ascribe social and sexual characteristics to female breasts, and may regard bare breasts in public as immodest or indecent. Breasts can represent fertility, femininity, or abundance. Breasts have been featured in ancient and modern sculpture, art, and photography.
== Bibliography == Boyd Orr, John (1905). Scotch Church Crisis: The Full Story of the Modern Phase of the Presbyterian Struggle. Glasgow: John M'Neilage. —————— (1929). Minerals in Pastures and Their Relation to Animal Nutrition. London: Lewis. —————— (1934). The National Food Supply and Its Influence on Public Health. London: King. —————— (1936). Food, Health and Income. London: Macmillan. —————— (1937). Nutritional Science and State Planning.in (Orr) —————— (1940). Nutrition in war. Fabian Tract 251. London: Fabian Society. —————— (1942). Fighting for What?. London: Macmillan. —————— (1943). Food and the People. London: Pilot Press. —————— (1945). Welfare and Peace. London: National Peace Council. —————— (1946). A Charter for Health. London: Allen & Unwin. —————— (1948). Food: The Foundation of World Unity. London: National Peace Council. —————— (1950). International Liaison Committee of Organisations for Peace: A New Strategy of Peace. London: National Peace Council. —————— (1957). Feast and famine: The wonderful world of food. London: Rathbone Books. —————— (1958). The Wonderful World of Food: The Substance of Life. Garden City, NY: Garden City Books. —————— (1966). As I recall: the 1880s to the 1960s. with an introduction by Ritchie Calder. London: MacGibbon & Kee. with other authors Boyd Orr, John; Lubbock, David (1940). Feeding the people in war time. London: Macmillan – via Internet Archive. Boyd Orr, John; Lubbock, David (1964) [First published 1953]. The White Man's Dilemma: Food and the Future (2nd ed.). London: Allen & Unwin. Boyd Orr, John (1968).
In 1992, Yugoslavia had also been drawn as the second seed in Group 5 of the European Zone in the qualifying tournament for the 1994 World Cup. FRY was barred from competing, rendering the group with only five remaining members instead of six. In 1994, when the boycott was lifted, the union of Serbia and Montenegro competed under the name "Yugoslavia", as the Federal Republic of Yugoslavia national football team. The Serbia and Montenegro national team continued under Yugoslavia's naming until 2003 when the country and team were renamed Serbia and Montenegro. The Serbia national football team inherited Yugoslavia's spot within FIFA and UEFA and is considered by both organizations as the only successor of Yugoslavia (and of Serbia and Montenegro).
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.